HAMILTON, Ontario, June 24, 2021 (GLOBE NEWSWIRE) – Reliq Health Technologies Inc. (TSXV: RHT or OTC: RQHTF or WKN: A2AJTB) (“Reliq“or the”Company“), a growing global telemedicine company that develops innovative virtual care solutions for the multi-billion dollar healthcare market, today provided an update on the recent expansion of Texas Medicaid’s telemonitoring program , which significantly increases the size of the patient population eligible for service.
“Since its inception in 2014, Texas Medicaid’s telemonitoring (remote patient monitoring) program has only covered patients with two conditions: hypertension and diabetes,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “With the recent passage of Bill HB-3740, effective September 1, 2021, the telemonitoring program in Texas expands significantly to include nine other eligible conditions: pregnancy, heart disease, cancer, chronic obstructive pulmonary disease, congestive heart failure, severe mental illness or emotional disturbances, asthma, myocardial infarction and stroke, more than doubling the size of the target patient population for Reliq in this condition. This significant change in the scope of Texas Medicaid’s telemonitoring program is in line with general trends in Medicare and Medicaid coverage for remote patient monitoring (RPM) and other virtual care services for chronically ill patients. Since the federal Medicare program first introduced its own billing code for RPM in 2018, the Centers for Medicare and Medicaid Services have systematically expanded covered virtual care services and total reimbursement amounts each year. Using Reliq’s iUGO Care platform and its modules for Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Behavioral Health Integration (BHI), Collaborative Care Management ( CoCM), Primary Care Management (PCM) and Transitional Care Management (TCM), Reliq customers can currently take advantage of over 18 different billing codes to deliver high quality healthcare to their patients remotely and generate new sources of high-profit income for their practices. The chronic disease management market is large and rapidly growing, and Reliq’s industry-leading, powerful and flexible iUGO Care platform is uniquely able to support healthcare providers looking to deliver new services. of virtual care to their patients.
Reliq Health Technologies is a rapidly growing global telemedicine company specializing in the development of innovative virtual care solutions for the billion dollar healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care enables complex patients to receive high quality care at home, improving health outcomes, improving the quality of life for patients and families, and reducing the cost of providing care. iUGO Care provides real-time access to remote patient monitoring data, enabling the healthcare team to intervene in a timely manner to avoid costly hospital readmissions and emergency room visits. Reliq Health Technologies trades on the TSX Venture Exchange under the symbol RHT, on the OTC under the name RQHTF and on the WKN under the name A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and director
For more information, please contact:
Investor Relations at [email protected]
Contact for U.S. Investor Relations
Lytham Partners, LLC
New York | Phoenix
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautions Regarding Forward-Looking Information
Certain statements contained in this press release constitute forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including, but not limited to, statements regarding estimates, plans, programs, forecasts, projections, goals, assumptions, expectations or beliefs regarding future performance, are “forward-looking statements”.
We caution you that these “forward-looking statements” involve known and unknown risks and uncertainties which could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, without limitation, statements regarding business operations, including technological development, anticipated revenues, projected market size and other information based on forecasts of future results, estimates of amounts not yet determinable and management assumptions.
Reliq Health Technologies Inc. (the “Company“) does not intend and assumes no obligation to update these forward-looking statements, except as required by law. These forward-looking statements involve risks and uncertainties relating, among other things, to technological development and marketing activities, historical activities of the Company technological development experience, uninsured risks Actual results may differ materially from those expressed or implied by these forward-looking statements.
SOURCE: Reliq Health Technologies Inc.